CLDA: Summary for Clinical Data, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 4:05am EST - Canadian Markets open in 5 hours and 25 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Clinical Data, Inc. (CLDA)

On Feb 9: 15.37 USD 0.00 (0.00%)

MORE ON CLDA

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Clinical Data, Inc. (NGM:CLDA) Delayed quote data

Last Trade:	15.37 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	15.37
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	28.80

Day's Range:	N/A - N/A
52wk Range:	7.36 - 21.94
Volume:	0
Avg Vol (3m):	100,287
Market Cap:	407.17M
P/E (ttm):	N/A
EPS (ttm):	-3.53
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add CLDA to Portfolio

Download Data

HEADLINES

•	CLINICAL DATA INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue 4:31pm)

•	Earnings roundup: Coca-Cola, Gartner
	AP (Tue 2:18pm)

•	Clinical Data 3Q loss narrows on sales boost
	AP (Tue 11:29am)

•	Clinical Data, Inc. Reports Third Quarter Fiscal 2010 Results
	Business Wire (Tue 7:21am)

•	Clinical Data, Inc. to Present at the BIO CEO & Investor Conference
	Business Wire (Tue, Feb 2)

•	[video] Trading Smallcap Biotech
	at TheStreet.com (Mon, Feb 1)

•	Loomis Sayles Fund Avoids Financials
	at TheStreet.com (Thu, Jan 28)

•	Clinical Data, Inc. to Present at J.P. Morgan Healthcare Conference
	Business Wire (Wed, Jan 6)

•	Clinical Data, Inc. Establishes Research Collaboration to Study Genetic Variants Associated with Response to Clopidogrel
	Business Wire (Tue, Dec 22)

•	Biotech Calendar: Upcoming FDA Dates
	at TheStreet.com (Tue, Dec 15)

More Headlines for CLDA...

ANALYST

EPS Est (next year) (Mar-10) :	-2.63
EPS Est (in 2 years) (Mar-11) :	-2.88
Avg Rec (current)*:	2.2
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Clinical Data, Inc. operates as a global biotechnology company developing early and late stage targeted therapeutics, as well as genetic and pharmacogenomic tests that detect serious diseases and help predict drug safety, tolerability, and efficacy.

Full Company Profile

Add to Portfolio

Email to a Friend

•